These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14634096)

  • 1. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice.
    Oikawa Y; Shimada A; Kasuga A; Morimoto J; Osaki T; Tahara H; Miyazaki T; Tashiro F; Yamato E; Miyazaki J; Saruta T
    J Immunol; 2003 Dec; 171(11):5865-75. PubMed ID: 14634096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
    Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
    J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
    Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
    J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.
    Rothe H; O'Hara RM; Martin S; Kolb H
    Diabetologia; 1997 Jun; 40(6):641-6. PubMed ID: 9222642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice.
    Bao M; Yang Y; Jun HS; Yoon JW
    J Immunol; 2002 May; 168(10):5369-75. PubMed ID: 11994496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
    Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
    J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
    Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
    Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
    J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice.
    Seifarth C; Pop S; Liu B; Wong CP; Tisch R
    J Immunol; 2003 Jul; 171(1):469-76. PubMed ID: 12817032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.
    Walz M; Overbergh L; Mathieu C; Kolb H; Martin S
    Horm Metab Res; 2002 Oct; 34(10):561-9. PubMed ID: 12439784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
    Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M
    Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice.
    Hill NJ; Van Gunst K; Sarvetnick N
    J Immunol; 2003 Feb; 170(4):1649-58. PubMed ID: 12574327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
    J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IFN-gamma and IL-10 levels are associated with disease progression in non-obese diabetic mice.
    Schloot NC; Hanifi-Moghaddam P; Goebel C; Shatavi SV; Flohé S; Kolb H; Rothe H
    Diabetes Metab Res Rev; 2002; 18(1):64-70. PubMed ID: 11921420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice.
    Rothe H; Hibino T; Itoh Y; Kolb H; Martin S
    J Autoimmun; 1997 Jun; 10(3):251-6. PubMed ID: 9218751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.